Cargando…
Osteoprotegerin and Cardiovascular Events in High‐Risk Populations: Meta‐Analysis of 19 Prospective Studies Involving 27 450 Participants
BACKGROUND: Osteoprotegerin is a cytokine involved in bone metabolism as well as vascular calcification and atherogenesis. Although circulating osteoprotegerin levels are robustly associated with incident cardiovascular disease (CVD) in the general population, its relevance as a biomarker among popu...
Autores principales: | Tschiderer, Lena, Klingenschmid, Gerhard, Nagrani, Rajini, Willeit, Johann, Laukkanen, Jari A., Schett, Georg, Kiechl, Stefan, Willeit, Peter |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6201389/ https://www.ncbi.nlm.nih.gov/pubmed/30369329 http://dx.doi.org/10.1161/JAHA.118.009012 |
Ejemplares similares
-
Osteoprotegerin concentration and risk of cardiovascular outcomes in nine general population studies: Literature-based meta-analysis involving 26,442 participants
por: Tschiderer, Lena, et al.
Publicado: (2017) -
Associations of Serum Dickkopf‐1 and Sclerostin With Cardiovascular Events: Results From the Prospective Bruneck Study
por: Klingenschmid, Gerhard, et al.
Publicado: (2020) -
Carotid intima‐media thickness predicts carotid plaque development: Meta‐analysis of seven studies involving 9341 participants
por: Tschiderer, Lena, et al.
Publicado: (2020) -
Physical activity and risk of atrial fibrillation in the general population: meta-analysis of 23 cohort studies involving about 2 million participants
por: Kunutsor, Setor K., et al.
Publicado: (2021) -
STROKE-CARD care to prevent cardiovascular events and improve quality of life after acute ischaemic stroke or TIA: A randomised clinical trial
por: Willeit, Peter, et al.
Publicado: (2020)